Vital Pulp Therapy Versus Root Canal Treatment for Irreversible Pulpitis With Incipient Apical Periodontitis Diagnosed Using Artificial Intelligence This Keeps: the Main Intervention (Vital Pulp Therapy) the Comparison (Root Canal Treatment) the Condition (Irreversible Pulpitis With Incipient Apic
Impact of Vital Pulp Therapy in Acute Irreversible Pulpitis With Incipient Apical Periodontitis Cases Diagnosed by the Aid of Artificial Intelligence: A Randomized Controlled Clinical Trial
1 other identifier
interventional
34
1 country
1
Brief Summary
This study evaluates postoperative pain and treatment outcomes following vital pulp therapy and root canal treatment in patients with symptomatic teeth. Participants will receive either vital pulp therapy or standard root canal treatment, and pain will be measured using standardized pain scores at different time intervals after treatment. The primary outcome is postoperative pain intensity in the early healing period. Secondary outcomes include long-term clinical and radiographic success at 6 months and 1 year. Radiographic outcomes will be assessed using artificial intelligence (AI)-assisted analysis to improve evaluation of healing and treatment success. The study aims to compare pain progression and long-term outcomes between the two treatment approaches.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 8, 2026
CompletedFirst Submitted
Initial submission to the registry
April 18, 2026
CompletedFirst Posted
Study publicly available on registry
April 24, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 8, 2027
ExpectedApril 24, 2026
November 1, 2025
5 months
April 18, 2026
April 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Score
Postoperative pain assessment using modified Visual Analogue Scale. Postoperative pain assessment after 24 hours and 1 week.
1 Week
Secondary Outcomes (1)
Clinical and AI- assisted Radiographic long term success rate of vital pulp therapy and Root Canal Treatment
1 Year
Study Arms (2)
Vital Pulp Therapy
ACTIVE COMPARATORParticipants receive vital pulp therapy for symptomatic teeth followed by postoperative pain assessment and radiographic follow-up.
Root Canal Treatment
ACTIVE COMPARATORParticipants receive conventional root canal treatment for symptomatic teeth followed by postoperative pain assessment and radiographic follow-up.
Interventions
Vital pulp therapy will be performed on symptomatic teeth according to clinical indication to preserve pulp vitality. Postoperative pain will be assessed using standardized pain scoring methods, and radiographic healing will be evaluated using AI-assisted analysis.
Conventional root canal treatment will be performed on symptomatic teeth according to standard clinical protocols. Postoperative pain will be assessed using standardized pain scoring methods, and radiographic healing will be evaluated using AI-assisted analysis.
Eligibility Criteria
You may qualify if:
- Mandibular molars with with deep caries exposing the pulp and preoperative symptoms, such as spontaneous or referred pain.
- Mandibular molars lacking noticeable radiolucency in the furcation or periapical areas. (Periapical Index scores of 1 and 2)
- Patients aged 18-40 years with teeth diagnosed with acute irreversible pulpitis and symptomatic apical periodontitis.
- Patients willing to provide written informed consent for participation in the study.
- Restorable teeth and adequate periodontal support.
You may not qualify if:
- Teeth with prior endodontic treatment or history of trauma.
- Teeth with internal or external resorption, prominent radiolucency at the periapical regions or furcation. (Periapical Index score of 3, 4 and 5)
- Teeth that are not responsive to vitality tests.
- Pregnant or lactating women due to potential risks associated with radiographic exposure.
- Patients with systemic diseases (e.g., uncontrolled diabetes, immunosuppression) that may affect healing.
- Teeth with advanced periodontal disease (e.g., mobility grade II or III, furcation involvement).
- Patients unable to attend follow-up appointments for up to one year.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University
Cairo, Cairo Governorate, 00202, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Abeer Elgendy, Professor
Ain Shams University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- This is an open-label study. No participants, care providers, investigators, or outcome assessors were blinded to the assigned intervention. Radiographic analysis was performed using standardized methods with AI-assisted evaluation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 18, 2026
First Posted
April 24, 2026
Study Start
November 15, 2025
Primary Completion
April 8, 2026
Study Completion (Estimated)
April 8, 2027
Last Updated
April 24, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because this is a single-center academic clinical study, and data sharing is not required by the study protocol or ethics approval. All published results will be reported in aggregate form to ensure participant confidentiality and data protection.